VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q57066466 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000121.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q57066466‏
024 ‎‡a 0000-0002-4866-731X‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q57066466‏
100 0 ‎‡a Emma Robinson‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a এমা রবিনসন‏ ‎‡9 bn‏
400 0 ‎‡a Emma Robinson‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Emma Robinson‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions: Where Do we Stand with Chemotherapyinduced Cardiotoxicity?‏
670 ‎‡a Author's Approaching Sex Differences in Cardiovascular Non-Coding RNA Research‏
670 ‎‡a Author's Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129‏
670 ‎‡a Author's Contractile responses to endothelin-1 are regulated by PKC phosphorylation of cardiac myosin binding protein-C in rat ventricular myocytes.‏
670 ‎‡a Author's Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors‏
670 ‎‡a Author's Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B‏
670 ‎‡a Author's Hepatocyte-Specific SR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1-Deficient Mice and Improves Pressure Overload-Induced Cardiomyopathy‏
670 ‎‡a Author's Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection‏
670 ‎‡a Author's Lnc'ing Ca2+, SERCA and cardiac disease‏
670 ‎‡a Author's Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers‏
670 ‎‡a Author's Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure‏
670 ‎‡a Author's Regulatory RNAs in Heart Failure‏
670 ‎‡a Author's Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes‏
670 ‎‡a Author's The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy‏
670 ‎‡a Author's The landscape of DNA repeat elements in human heart failure‏
670 ‎‡a Author's The Missing "lnc" between Genetics and Cardiac Disease‏
909 ‎‡a (orcid) 000000024866731x‏ ‎‡9 1‏
919 ‎‡a hepatocytespecificsrbigenetransfercorrectscardiacdysfunctioninscarb1deficientmiceandimprovespressureoverloadinducedcardiomyopathy‏ ‎‡A Hepatocyte-Specific SR-BI Gene Transfer Corrects Cardiac Dysfunction in Scarb1-Deficient Mice and Improves Pressure Overload-Induced Cardiomyopathy‏ ‎‡9 1‏
919 ‎‡a experimentalheartfailuremodelledbythecardiomyocytespecificlossofanepigenomemodifierdnmt3b‏ ‎‡A Experimental heart failure modelled by the cardiomyocyte-specific loss of an epigenome modifier, DNMT3B‏ ‎‡9 1‏
919 ‎‡a endothelin1promoteshypertrophicremodellingofcardiacmyocytesbyactivatingsustainedsignallingandtranscriptiondownstreamofendothelintypeareceptors‏ ‎‡A Endothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors‏ ‎‡9 1‏
919 ‎‡a contractileresponsestoendothelin1areregulatedbypkcphosphorylationofcardiacmyosinbindingprotein100inratventricularmyocytes‏ ‎‡A Contractile responses to endothelin-1 are regulated by PKC phosphorylation of cardiac myosin binding protein-C in rat ventricular myocytes.‏ ‎‡9 1‏
919 ‎‡a catalyzingtranscriptomicsresearchincardiovasculardiseasethecardiornacostactionca17129‏ ‎‡A Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129‏ ‎‡9 1‏
919 ‎‡a resistancetoretinopathydevelopmentinobesediabeticandhypertensivezsf1ratsanexcitingmodeltoidentifyprotectivegenes‏ ‎‡A Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes‏ ‎‡9 1‏
919 ‎‡a approachingsexdifferencesincardiovascularnoncodingrnaresearch‏ ‎‡A Approaching Sex Differences in Cardiovascular Non-Coding RNA Research‏ ‎‡9 1‏
919 ‎‡a regulatoryrnasinheartfailure‏ ‎‡A Regulatory RNAs in Heart Failure‏ ‎‡9 1‏
919 ‎‡a anthracyclinerelatedheartfailurecertainknowledgeandopenquestionswheredowestandwithchemotherapyinducedcardiotoxicity‏ ‎‡A Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions: Where Do we Stand with Chemotherapyinduced Cardiotoxicity?‏ ‎‡9 1‏
919 ‎‡a myofibroblastphenotypeandreversibilityoffibrosisinpatientswithendstageheartfailure‏ ‎‡A Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure‏ ‎‡9 1‏
919 ‎‡a mutationsinpdlim5arerareindilatedcardiomyopathybutareemergingaspotentialdiseasemodifiers‏ ‎‡A Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers‏ ‎‡9 1‏
919 ‎‡a h3k9dimethyltransferasesehmt12protectagainstpathologicalcardiachypertrophy‏ ‎‡A The H3K9 dimethyltransferases EHMT1/2 protect against pathological cardiac hypertrophy‏ ‎‡9 1‏
919 ‎‡a missinglncbetweengeneticsandcardiacdisease‏ ‎‡A The Missing "lnc" between Genetics and Cardiac Disease‏ ‎‡9 1‏
919 ‎‡a landscapeofdnarepeatelementsinhumanheartfailure‏ ‎‡A The landscape of DNA repeat elements in human heart failure‏ ‎‡9 1‏
919 ‎‡a lncingca2+sercaandcardiacdisease‏ ‎‡A Lnc'ing Ca2+, SERCA and cardiac disease‏ ‎‡9 1‏
919 ‎‡a humanembryonicstemcellderivedcardiomyocyteplatformscreensinhibitorsofsarscov2infection‏ ‎‡A Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 BIBSYS|1542227324254
996 ‎‡2 SUDOC|196256836
996 ‎‡2 PLWABN|9810535647405606
996 ‎‡2 J9U|987007375681705171
996 ‎‡2 RERO|A003752030
996 ‎‡2 ISNI|0000000483074389
996 ‎‡2 J9U|987007314874705171
996 ‎‡2 SUDOC|156466058
996 ‎‡2 NTA|421511893
996 ‎‡2 BIBSYS|90121906
996 ‎‡2 J9U|987007326033405171
996 ‎‡2 SUDOC|081488831
996 ‎‡2 LC|n 2007165496
996 ‎‡2 LC|n 2007090346
996 ‎‡2 LC|nb2012017265
996 ‎‡2 NTA|136314147
996 ‎‡2 LC|nb2011009989
996 ‎‡2 N6I|vtls002452691
996 ‎‡2 LNB|LNC10-000346959
996 ‎‡2 SUDOC|100491928
996 ‎‡2 ISNI|0000000074283454
996 ‎‡2 LC|no2015043632
996 ‎‡2 LC|n 2017182542
996 ‎‡2 LC|n 85008840
996 ‎‡2 SUDOC|273729306
996 ‎‡2 RERO|A003752017
996 ‎‡2 DNB|1176689045
996 ‎‡2 LC|no2019103767
996 ‎‡2 RERO|A003752018
996 ‎‡2 J9U|987007274901505171
996 ‎‡2 BAV|495_249453
996 ‎‡2 DNB|1219988669
996 ‎‡2 BAV|495_249454
996 ‎‡2 NUKAT|n 2009105512
996 ‎‡2 NKC|xx0023409
996 ‎‡2 NTA|363988904
996 ‎‡2 ISNI|0000000025255289
996 ‎‡2 LC|n 88068059
996 ‎‡2 BNF|17868154
996 ‎‡2 RERO|A027756119
996 ‎‡2 DNB|1142184099
996 ‎‡2 NTA|160369452
996 ‎‡2 ISNI|0000000109498587
996 ‎‡2 LC|n 2014187328
996 ‎‡2 ISNI|0000000036175831
996 ‎‡2 LC|n 82158400
996 ‎‡2 DNB|136679455
996 ‎‡2 NKC|xx0312738
996 ‎‡2 DNB|1319489524
996 ‎‡2 PLWABN|9811263828905606
996 ‎‡2 ISNI|000000040146144X
996 ‎‡2 ISNI|0000000038446121
996 ‎‡2 DNB|113727249X
996 ‎‡2 DNB|132967992X
996 ‎‡2 LC|n 85064118
996 ‎‡2 ISNI|0000000077926371
996 ‎‡2 ISNI|0000000456017928
996 ‎‡2 PTBNP|140205
996 ‎‡2 NUKAT|n 2018253424
996 ‎‡2 BNF|12520812
996 ‎‡2 CAOONL|ncf11055131
996 ‎‡2 LC|n 2024002049
996 ‎‡2 ISNI|0000000042065540
996 ‎‡2 DNB|104250402
996 ‎‡2 LC|no2014047642
996 ‎‡2 SZ|136679455
996 ‎‡2 BIBSYS|90401189
996 ‎‡2 LC|no 98062060
996 ‎‡2 N6I|vtls000014499
996 ‎‡2 BIBSYS|90232199
996 ‎‡2 NTA|44365039X
996 ‎‡2 NII|DA12807014
996 ‎‡2 PTBNP|249762
996 ‎‡2 LC|no2010060458
996 ‎‡2 ISNI|0000000082524078
996 ‎‡2 LC|nb2006010918
996 ‎‡2 ISNI|000000006300435X
996 ‎‡2 LC|no 95040035
996 ‎‡2 ISNI|0000000030795810
996 ‎‡2 SUDOC|236915207
996 ‎‡2 LC|no2013021229
996 ‎‡2 DNB|1318722292
996 ‎‡2 NLA|000035766257
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏